FDA-Approved Ruxolitinib in Patients with Myelofibrosis: the Stanford Experience

被引：0

|

作者：

Nguyen, Huong ^{[1
]}

Anh Pham ^{[1
]}

Perkins, Cecelia ^{[1
]}

Linder, Andrea ^{[1
]}

Fechter, Lenn ^{[1
]}

Gotlib, Jason ^{[1
]}

机构：

[1] Stanford Univ, Sch Med, Stanford, CA 94305 USA

来源：

BLOOD | 2012年 / 120卷 / 21期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1747

引用

收藏

页数：2

相关论文

共 50 条

[41] NONAPPROVED USES OF FDA-APPROVED DRUGS
ANDERSON, BJ
JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1970, 211 (10): : 1705 - &
[42] NIH Support for FDA-Approved Medicines
Griesenauer, Rebekah H.
Moore, Ryan
Kinch, Michael S.
CELL CHEMICAL BIOLOGY, 2017, 24 (11): : 1315 - 1316
[43] Recent changes to FDA-approved labeling
不详
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2004, 61 (18) : 1880 - 1880
[44] Recent changes to FDA-approved labeling
不详
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2002, 59 (07) : 606 - 606
[45] Newly FDA-approved psychotropic medications
Naguy, Ahmed
Pridmore, Saxby
Alamiri, Bibi
ASIAN JOURNAL OF PSYCHIATRY, 2022, 77
[46] An overview of FDA-approved vaccines & their innovators
Griesenauer, Rebekah H.
Kinch, Michael S.
EXPERT REVIEW OF VACCINES, 2017, 16 (12) : 1253 - 1266
[47] An analysis of FDA-approved drugs for oncology
Kinch, Michael S.
DRUG DISCOVERY TODAY, 2014, 19 (12) : 1831 - 1835
[48] FDA-approved drug promotes remyelination
不详
NATURE REVIEWS NEUROLOGY, 2022, 18 (11) : 637 - 637
[49] Recent changes to FDA-approved labeling
不详
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2002, 59 (23) : 2284 - 2284
[50] Illegitimate companies threaten patients' receipt of FDA-approved drugs
Thompson, Cheryl A.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2013, 70 (19) : 1646 - 1647

← 1 2 3 4 5 →